Trial intelligence / Profile preview

Toremifene for Desmoid Tumors

NCT00002595Phase 2Completed

Sponsor
Advocate Lutheran General Hospital
Start
Jul 1991
Primary completion
May 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of toremifene in desmoid tumor, sponsored by Advocate Lutheran General Hospital. Started Jul 1991; status: completed.

02

Drugs

toremifene
03

Conditions

desmoid tumor

Beyond the preview

Go deeper on NCT00002595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call